Observation on the effect of rosiglitazone on blood pressure in type 2 diabetes mellitus

( views:112, downloads:0 )
Author:
CHEN Ming-wei()
()
WANG You-min()
WANG Chang-jiang()
()
()
()
()
()
()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 15, Issue 02, 2007
DOI:
Key Word:

Abstract:

  • [1]Lebovitz HE,Dole JF,Patwardhan R,et al.Rosiglitazone monotherapy is effective in patients with type 2 diabetes.J Clin Endocrinol Metab,2001,86:280-288.
  • [2]Walker AB,Chattington PD,Buckingham RE,et al,The thiazolidione rosiglitazone(BRL 49653)lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.Diabetes,1999,48:1448-1453.
  • [3]Sarafidis PA,Lasaridis AN,Nilsson PM,et al.Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase.J Hypertens,2004,22:1769-1777.
  • [4]Shargorodsky M,Wainstein J,Gavish D,et al.Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus.Am J Hypertens,2003,16:617-622.
  • [5]李光伟,王金平,李春梅,等.胰岛素增敏剂罗格列酮抗高血压作用探讨.中华内科杂志,2004,43:907-910.
  • [6]Honisett SY,Stojanovska L,Sudhir K,et al.Rosiglitazone lowers blood pressure and increases arterial compliance in postmenopausal women with type 2 diabetes.Diabetes Care,2003,26:3194-3195.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn